Citigroup restated their buy rating on shares of GSK (LON:GSK – Free Report) in a research note released on Tuesday, Marketbeat.com reports. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 2,100 target price on shares of GSK in a research report on Wednesday, January 7th. UBS Group reiterated a “neutral” rating and issued a GBX 1,940 price target on shares of GSK in a research report on Friday, January 23rd. JPMorgan Chase & Co. restated an “underweight” rating on shares of GSK in a report on Wednesday, January 7th. Three research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company.